You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Investigators identified an inbred individual who appeared to be part of a high-status group buried in lavish tombs during the Neolithic period.
In Cell this week: catalog of structural variants within the human genome, proteomic and metabolomic profiles of COVID-19 patients' blood, and more.
The launch of the company's Prism system earlier this month should support the development of an accompanying menu of tests to serve diverse users.
The Rida Gene SARS-CoV-2 test runs on the Roche LightCycler 480II and is intended for use in hospital, reference, private, and state laboratories.
The company is providing DNA/RNA extraction kits, viral RNA isolation platforms, workstations, and kits for detecting nucleic acids from the coronavirus to the lab.
New Scientist describes next steps supporters of the #ShutdownSTEM strike could take to combat racism in academia.
In PNAS this week: features linked to coronavirus pathogenicity, multi-system syndrome linked to RNA modification-linked mutations, and more.
Yourgene will provide molecular COVID-19 testing to corporate clients of Caxton, who will obtain their results through Hooha Innovations' Prova app.
Roche will have non-exclusive access to SpeeDx's existing tests and technology to enable expansion of diagnostic products for antibiotic resistance in STIs.
The sequencing instrument developer is in the process of scaling and optimizing its silicon chips and plans to offer its platform by the end of next year.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.